Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Vaxart, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 100 | 2 | 93 | −5 |
| Shares | 37.6M | 200.7K | 35.7M | −1.63M (−4.4%) |
| Value | $31.9M | $170.4K | $23.7M | −$8.06M (−25.4%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Vaxart, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 501,623 | $332.1K | 0.00% |
| Raymond James Financial Inc | 195,448 | $129.4K | 0.00% |
| HRT Financial LP | 91,270 | $60.0K | 0.00% |
| Kingswood Wealth Advisors, LLC | 30,005 | $19.9K | 0.00% |
| Two Sigma Advisers, LP | 24,700 | $16.4K | 0.00% |
| Breakwater Capital Group | 24,000 | $15.9K | 0.00% |
| Shay Capital LLC | 10,513 | $6.96K | 0.00% |
| SBI Securities Co., Ltd. | 7,003 | $4.64K | 0.00% |
| MAI Capital Management | 1,000 | $663 | 0.00% |
| Transce3nd, LLC | 235 | $156 | 0.00% |
| GeoWealth Management, LLC | 100 | $66 | 0.00% |
| Synergy Investment Management, LLC | 30 | $20 | 0.00% |
| Golden State Wealth Management, LLC | 1 | $1 | 0.00% |
Sold out (18)
Institutions that held Vaxart, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Monaco Asset Management SAM | 164,334 | $139.5K |
| Goldman Sachs Group Inc | 125,541 | $106.6K |
| Price T Rowe Associates Inc | 78,500 | $67.0K |
| Marshall Wace, LLP | 67,484 | $57.4K |
| Qube Research & Technologies Ltd | 53,259 | $45.2K |
| Pale Fire Capital SE | 51,028 | $43.3K |
| GTS Securities LLC | 32,670 | $27.7K |
| Kestra Advisory Services, LLC | 16,919 | $14.4K |
| Koss-Olinger Consulting, LLC | 16,000 | $14.0K |
| Ground Swell Capital, LLC | 12,025 | $10.2K |
| Thompson Davis & Co., Inc. | 12,000 | $10.2K |
| AdvisorNet Financial, Inc | 700 | $594 |
| Central Trust Co | 500 | $425 |
| Federation des caisses Desjardins du Quebec | 400 | $340 |
| Macroview Investment Management LLC | 361 | $307 |
| Country Trust Bank | 300 | $255 |
| CWM, LLC | 10 | $0 |
| International Assets Investment Management, LLC | 85 | – |
Not filed for Q4 2024 yet (2)
Institutions that held Vaxart, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 188,384 | $159.9K |
| Raymond James & Associates | 12,279 | $10.4K |